BBA
VRTX icon

Baader Bank Aktiengesellschaft’s Vertex Pharmaceuticals VRTX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Sell
5,280
-8,324
-61% -$3.88M 0.18% 104
2025
Q4 		$6.16M Buy
+13,604
New +$5.86M 0.42% 53
2025
Q3 		– Sell
-2,357
Closed -$1.05M – 610
2025
Q2 		$1.05M Buy
2,357
+1,247
+112% +$575K 0.08% 178
2025
Q1 		$513K Sell
1,110
-1,366
-55% -$637K 0.04% 228
2024
Q4 		$997K Buy
2,476
+38
+2% +$17.6K 0.07% 168
2024
Q3 		$1.12M Buy
2,438
+45
+2% +$21.6K 0.07% 166
2024
Q2 		$1.12M Buy
2,393
+558
+30% +$242K 0.07% 171
2024
Q1 		$767K Buy
1,835
+325
+22% +$137K 0.05% 185
2023
Q4 		$614K Sell
1,510
-464
-24% -$171K 0.04% 189
2023
Q3 		$686K Buy
1,974
+6
+0.3% +$2.1K 0.05% 178
2023
Q2 		$691K Sell
1,968
-266
-12% -$89.6K 0.03% 208
2023
Q1 		$702K Buy
2,234
+24
+1% +$7.2K 0.04% 209
2022
Q4 		$638K Hold
2,210
– – 0.03% 239
2022
Q3 		$640K Sell
2,210
-420
-16% -$121K 0.04% 231
2022
Q2 		$741K Buy
+2,630
New +$704K 0.06% 215

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baader Bank Aktiengesellschaft's VRTX Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its Vertex Pharmaceuticals (VRTX) stake by 61% in Q1 2026, selling an estimated $3.88M and leaving 5,280 shares worth $2.36M. The position accounts for 0.18% of the portfolio, ranked #104.

Baader Bank Aktiengesellschaft first reported a position in VRTX in Q2 2022 and has held it in 15 quarters since. The position peaked at $6.16M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 5,280 shares of Vertex Pharmaceuticals worth $2.36M as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 8,324 Vertex Pharmaceuticals shares in Q1 2026, an estimated $3.88M.
  • Vertex Pharmaceuticals made up 0.18% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #104 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • Baader Bank Aktiengesellschaft's Vertex Pharmaceuticals position peaked at $6.16M in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.